C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma
Members of the nuclear factor-κB (NF-κB) family of transcriptional regulators are central mediators of the cellular inflammatory response. Although constitutive NF-κB signalling is present in most human tumours, mutations in pathway members are rare, complicating efforts to understand and block aber...
Uloženo v:
| Vydáno v: | Nature (London) Ročník 506; číslo 7489; s. 451 - 455 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
Nature Publishing Group UK
27.02.2014
Nature Publishing Group |
| Témata: | |
| ISSN: | 0028-0836, 1476-4687, 1476-4687 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | Members of the nuclear factor-κB (NF-κB) family of transcriptional regulators are central mediators of the cellular inflammatory response. Although constitutive NF-κB signalling is present in most human tumours, mutations in pathway members are rare, complicating efforts to understand and block aberrant NF-κB activity in cancer. Here we show that more than two-thirds of supratentorial ependymomas contain oncogenic fusions between
RELA
, the principal effector of canonical NF-κB signalling, and an uncharacterized gene,
C11orf95
. In each case,
C11orf95
–
RELA
fusions resulted from chromothripsis involving chromosome 11q13.1. C11orf95–RELA fusion proteins translocated spontaneously to the nucleus to activate NF-κB target genes, and rapidly transformed neural stem cells—the cell of origin of ependymoma—to form these tumours in mice. Our data identify a highly recurrent genetic alteration of
RELA
in human cancer, and the C11orf95–RELA fusion protein as a potential therapeutic target in supratentorial ependymoma.
At least two-thirds of supratentorial ependymomas contain oncogenic fusions between
RELA
, the principal effector of nuclear factor-κB (NF-κB) signalling, and uncharacterized gene
C11orf95
; C11orf95–RELA fusion proteins translocate spontaneously to the nucleus to activate NF-κB target genes, and rapidly transform neural stem cells to form tumours in mice
Genomic analyses of childhood ependymomas
In this issue of
Nature
two groups present independent genomic analyses on ependymomas, a type of tumour that occurs throughout the nervous system, but most commonly in the hindbrain in children. Mack
et al
. found a low overall mutation rate and no significant recurrent mutations in 47 hindbrain ependymomas. But posterior fossa group B tumours, a subgroup found predominantly in infants and associated with poor prognosis, were distinguished by a CpG island methylator phenotype. This subgroup is shown to be susceptible to various compounds that target epigenetic modifications, including an EZH2 inhibitor that showed efficacy in a mouse xenograft model. Parker
et al
. found the
C11orf95–RELA
fusion gene in about 70% of supratentorial tumours, but not in other ependymoma subgroups. The gene fusions arise through chromothripsis and lead to the expression of a fusion protein that constitutively activates NF-κB signalling. In a mouse model, expression of
C11orf95–RELA
in neural stem cells leads to the formation of brain tumours. These findings identify NF-κB signalling as a possible therapeutic target in patients with this type of ependymoma. |
|---|---|
| Bibliografie: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to the work. |
| ISSN: | 0028-0836 1476-4687 1476-4687 |
| DOI: | 10.1038/nature13109 |